semaglutide glp Understanding (GLP-1 RA): Are they the right choice for weight loss? GLP-1 weight-loss drugs may also

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved for treating type 2 diabetes and obesity and are under investigation as potential treatments for substance use disorders (SUD)

Greater Patient Eligibility and Uptake: Updated ADA/EASD guidelines indicate that approximately 82 percent of U.S

included in the analysis 3 GLP-1RA trials with 17,072 participants, of whom 1,743 were on an SGLT2i

R.AlsulimaniA.FagooneeS.SlamaP.KesariK

Consistent with transcriptomic suppression of glycolytic and mitochondrial pathways, melatonin-treated ILC2s exhibited marked functional alterations in glucose utilization and oxidative metabolism ( Figures 5GS )